FDA Inspection 1150253 — UC Reproductive Medicine at Kettering
The FDA completed an inspection of UC Reproductive Medicine at Kettering on August 25, 2021 in Kettering, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 25, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Kettering, OH (United States)